CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis

Autor: Richter, J., Benson, V., Grobarova, V., Svoboda, J., Vencovsky, J., Svobodova, R., Fiserova, A.
Zdroj: In Clinical Immunology 2010 136(1):139-147
Databáze: ScienceDirect